Assertio Holdings | DEPO - Cost Of Sales

Stock Price
12.38
Daily Change
0.17 1.35%
Monthly
21.20%
Yearly
-1.97%
Q1 Forecast
0.88

Assertio Holdings reported $8.89M in Cost of Sales for its fiscal quarter ending in June of 2024.





Cost Of Sales Change Date
ANI Pharmaceuticals USD 116.02M 18.12M Sep/2025
Assertio Holdings USD 8.89M 2.29M Jun/2024
Aurora Cannabis CAD 58.08M 11.99M Sep/2025
Cara Therapeutics USD 0 0 Mar/2025
Daiichi Sankyo JPY 118.28B 37.7B Dec/2025
Ironwood Pharmaceuticals USD 29.83M 560K Sep/2024
J&J USD 7.97B 689M Dec/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Merck USD 3.32B 531M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Omeros USD 33.16M 18.52M Jun/2024
Pfizer USD 6.29B 2.12B Dec/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025